Literature DB >> 23665118

In vitro catheter and sorbent-based method for clearance of radiocontrast material during cerebral interventions.

George O Angheloiu1, Heribert Hänscheid, Christoph Reiners, William D Anderson, John A Kellum.   

Abstract

BACKGROUND: Contrast-induced acute kidney injury is a severe condition resulting from the use of radiology contrast in patients with predisposing factors. HYPOTHESIS: We hypothesized that a novel system including a device containing polymer resin sorbent beads and a custom-made suctioning catheter could efficiently remove contrast from an in vitro novel model of circulatory system (MOCS) mimicking the cerebral circulation.
METHODS: A custom-made catheter was built and optimized for cerebral venous approach. The efficiency of a system made of a polymer resin sorbent beads column (CST 401, Cytosorbents) and this particular catheter was tested in the MOCS running a solution composed of 0.9% saline and radio-contrast. During two series of 18 cycles of first-pass experiments we assessed the catheter's suctioning efficiency and the system's ability to clear radio-contrast injected into the MOCS's cerebral arterial segment. We also assessed the functioning and reliability of the MOCS.
RESULTS: Mean suctioning efficiency of the catheter was 84% ± 24%. The polymer sorbent column contrast removal rate was initially 96% and gradually decreased with subsequent cycles in a linear fashion during an experiment lasting approximately 90 minutes. The MOCS had a reliability of 0.9946×min(-1) where 1 × min(-1) was the optimum value.
CONCLUSION: A system including a polymer resin sorbent beads column and a custom-made suctioning catheter had an excellent initial efficiency in quickly removing contrast from an artificial MOCS mimicking the cerebral circulation. MOCS is an inexpensive and relatively reliable custom-made system that can be used for training or testing purposes.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Catheter; Contrast; MOCS; Nephropathy; Sorbent

Mesh:

Substances:

Year:  2013        PMID: 23665118     DOI: 10.1016/j.carrev.2013.03.001

Source DB:  PubMed          Journal:  Cardiovasc Revasc Med        ISSN: 1878-0938


  4 in total

Review 1.  Mechanistic Considerations and Pharmacokinetic Implications on Concomitant Drug Administration During CytoSorb Therapy.

Authors:  Joerg Scheier; Peter J Nelson; Antoine Schneider; Sébastien Colombier; Detlef Kindgen-Milles; Efthymios N Deliargyris; Thomas D Nolin
Journal:  Crit Care Explor       Date:  2022-05-09

Review 2.  Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb®-Basics, Indications and Perspectives-A Scoping Review.

Authors:  Thomas Köhler; Elke Schwier; Janina Praxenthaler; Carmen Kirchner; Dietrich Henzler; Claas Eickmeyer
Journal:  Int J Mol Sci       Date:  2021-11-26       Impact factor: 5.923

3.  Ticagrelor Removal From Human Blood.

Authors:  George O Angheloiu; Gabriel B Gugiu; Cristian Ruse; Rishikesh Pandey; Ramachandra R Dasari; Carl Whatling
Journal:  JACC Basic Transl Sci       Date:  2017-04-24

4.  In-Vitro Sorbent-Mediated Removal of Edoxaban from Human Plasma and Albumin Solution.

Authors:  Alexandra A Angheloiu; Yanglan Tan; Cristian Ruse; Scott A Shaffer; George O Angheloiu
Journal:  Drugs R D       Date:  2020-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.